SpringWorks Therapeutics Reports Third Quarter 2022
– Presented Positive Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for...
Source: globenewswire.com
Stay updated with breaking news from Presented Positive Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Presented Positive Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for...